News Center | AbbVie News Center
https://news.abbvie.com/news/abbvie-to-acquire-pharmacyclics-including-its-blockbuster-product-imbruvica-creating-an-industry-leading-hematological-oncology-franchise.htm
WebAbbVie, a global biopharmaceutical company, announced its plan to buy Pharmacyclics, the maker of Imbruvica, a breakthrough drug for blood cancers. Learn more about this deal and how it will enhance AbbVie's leadership in hematological oncology.
DA: 91 PA: 22 MOZ Rank: 85